Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soo Yoon

Showing results (1091-1100 of 1,104) with videos related to

Pageof 111
Sort By:
The Korean Journal of Internal Medicine|July 11, 2022
Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemiaYoung Hoon Park, Dae-Young Kim, Yeung-Chul Mun, et al.
Brain Tumor Research and Treatment|November 6, 2019
The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade III Cerebral Gliomas in Adults: Version 2019.01Young Zoon Kim, Chae Yong Kim, Jaejoon Lim, et al.
Brain Tumor Research and Treatment|November 6, 2019
The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade II Cerebral Gliomas in Adults: Version 2019.01Young Zoon Kim, Chae Yong Kim, Chan Woo Wee, et al.
The Lancet. Oncology|September 23, 2014
Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trialJesús F San-Miguel, Vânia T M Hungria, Sung-Soo Yoon, et al.
Blood|June 13, 2015
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemiaDae-Young Kim, Young-Don Joo, Sung-Nam Lim, et al.
Brain Tumor Research and Treatment|May 8, 2019
The Korean Society for Neuro-Oncology (KSNO) Guideline for Glioblastomas: Version 2018.01Young Zoon Kim, Chae Yong Kim, Jaejoon Lim, et al.
Acta Haematologica|November 6, 2009
Clinical features and survival outcomes in patients with multiple myeloma: analysis of web-based data from the Korean Myeloma RegistrySeok Jin Kim, Kihyun Kim, Byung Soo Kim, et al.
Journal of Pediatric Hematology/Oncology|November 27, 2013
Clinical features and treatment outcomes of Langerhans cell histiocytosis: a nationwide survey from Korea histiocytosis working partyBo Eun Kim, Kyung-Nam Koh, Jin Kyung Suh, et al.
Nature Genetics|October 6, 2015
Integrated molecular analysis of adult T cell leukemia/lymphomaKeisuke Kataoka, Yasunobu Nagata, Akira Kitanaka, et al.
Blood Research|February 4, 2025
Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questionsSung-Hoon Jung, Youngil Koh, Min Kyoung Kim, et al.
Pageof 111

Showing results (1091-1100 of 1,104) with videos related to

Sort By:
Pageof 111
The Korean Journal of Internal Medicine|July 11, 2022
Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemiaYoung Hoon Park, Dae-Young Kim, Yeung-Chul Mun, et al.
Brain Tumor Research and Treatment|November 6, 2019
The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade III Cerebral Gliomas in Adults: Version 2019.01Young Zoon Kim, Chae Yong Kim, Jaejoon Lim, et al.
Brain Tumor Research and Treatment|November 6, 2019
The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade II Cerebral Gliomas in Adults: Version 2019.01Young Zoon Kim, Chae Yong Kim, Chan Woo Wee, et al.
The Lancet. Oncology|September 23, 2014
Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trialJesús F San-Miguel, Vânia T M Hungria, Sung-Soo Yoon, et al.
Blood|June 13, 2015
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemiaDae-Young Kim, Young-Don Joo, Sung-Nam Lim, et al.
Brain Tumor Research and Treatment|May 8, 2019
The Korean Society for Neuro-Oncology (KSNO) Guideline for Glioblastomas: Version 2018.01Young Zoon Kim, Chae Yong Kim, Jaejoon Lim, et al.
Acta Haematologica|November 6, 2009
Clinical features and survival outcomes in patients with multiple myeloma: analysis of web-based data from the Korean Myeloma RegistrySeok Jin Kim, Kihyun Kim, Byung Soo Kim, et al.
Journal of Pediatric Hematology/Oncology|November 27, 2013
Clinical features and treatment outcomes of Langerhans cell histiocytosis: a nationwide survey from Korea histiocytosis working partyBo Eun Kim, Kyung-Nam Koh, Jin Kyung Suh, et al.
Nature Genetics|October 6, 2015
Integrated molecular analysis of adult T cell leukemia/lymphomaKeisuke Kataoka, Yasunobu Nagata, Akira Kitanaka, et al.
Blood Research|February 4, 2025
Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questionsSung-Hoon Jung, Youngil Koh, Min Kyoung Kim, et al.
Pageof 111